We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.37B
AUM Growth
-$224M
Cap. Flow
-$309M
Cap. Flow %
-22.53%
Top 10 Hldgs %
17.96%
Holding
216
New
21
Increased
69
Reduced
53
Closed
28

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$29M
2
MXCT icon
MaxCyte
MXCT
+$14.8M
3
SKIN icon
SkinHealth Systems
SKIN
+$8.7M
4
JBTM
JBT Marel
JBTM
+$7.82M
5
EXE
Expand Energy Corp
EXE
+$7.8M

Top Sells

Rank Stock Value
1
ZLAB icon
Zai Lab
ZLAB
+$25.1M
2
INSP icon
Inspire Medical Systems
INSP
+$21.2M
3
TXG icon
10x Genomics
TXG
+$21.1M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20.2M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$13.4M

Sector Composition

Rank Sector Weight
1 Healthcare 35.81%
2 Technology 14.81%
3 Financials 9.02%
4 Industrials 8.86%
5 Consumer Discretionary 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPG icon
51
Simon Property Group
SPG
$72.3B
$10.5M 0.76%
80,482
-13,651
-15% -$1.78M
SKIN icon
52
SkinHealth Systems
SKIN
$85.7M
$10.3M 0.75%
+395,494
New +$8.7M
SMAR
53
DELISTED
Smartsheet Inc.
SMAR
$10M 0.73%
145,589
+4,705
+3% +$346K
TPTX
54
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9.93M 0.72%
149,425
-75,451
-34% -$5.38M
SHOO icon
55
Steven Madden
SHOO
$3.55B
$9.74M 0.71%
242,560
+10,157
+4% +$420K
MASS icon
56
908 Devices
MASS
$364M
$9.36M 0.68%
287,815
-70,043
-20% -$2.38M
CLAR icon
57
Clarus
CLAR
$143M
$9.28M 0.68%
361,955
+8,679
+2% +$240K
NVDA icon
58
NVIDIA
NVDA
$5.42T
$8.8M 0.64%
424,610
+3,170
+0.8% +$65.8K
MS icon
59
Morgan Stanley
MS
$340B
$8.76M 0.64%
90,000
– –
TCBI icon
60
Texas Capital Bancshares
TCBI
$4.32B
$8.68M 0.63%
144,667
+50,155
+53% +$3.12M
BOOT icon
61
Boot Barn
BOOT
$4.95B
$8.51M 0.62%
95,735
+42,715
+81% +$3.68M
EVBG
62
DELISTED
Everbridge, Inc. Common Stock
EVBG
$8.24M 0.6%
54,569
+2,121
+4% +$314K
NVCR icon
63
NovoCure
NVCR
$1.91B
$7.97M 0.58%
68,593
-16,434
-19% -$2.48M
JBTM
64
JBT Marel
JBTM
$6.39B
$7.67M 0.56%
+54,547
New +$7.82M
VTGN icon
65
VistaGen Therapeutics
VTGN
$12.8M
$7.63M 0.56%
92,878
+1,082
+1% +$94K
FITB
66
Fifth Third Bancorp
FITB
$51.8B
$7.43M 0.54%
175,000
+35,000
+25% +$1.34M
TEAM icon
67
Atlassian
TEAM
$37.8B
$7.31M 0.53%
18,677
+471
+3% +$157K
OMIC
68
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$7.27M 0.53%
21,660
+669
+3% +$343K
SLGC
69
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$7.21M 0.53%
+581,604
New +$6.56M
CHGG icon
70
Chegg
CHGG
$102M
$6.95M 0.51%
102,203
-24,971
-20% -$2.03M
CRWD icon
71
CrowdStrike
CRWD
$218B
$6.91M 0.5%
112,496
+2,412
+2% +$156K
RRX icon
72
Regal Rexnord
RRX
$11.9B
$6.54M 0.48%
43,497
+8,768
+25% +$1.26M
AMRC icon
73
Ameresco
AMRC
$1.36B
$6.36M 0.46%
108,781
+1,380
+1% +$90.9K
DOW icon
74
Dow Inc
DOW
$21.2B
$6.33M 0.46%
110,000
– –
VERV
75
DELISTED
Verve Therapeutics
VERV
$6.22M 0.45%
+132,300
New +$7.78M
1 2
3
4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Nicholas Investment Partners held 216 positions worth $1.37B, down 14% from $1.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $309M in Q3 2021, closing 28 positions and reducing 53 holdings. Its most notable exit was Zai Lab, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 45% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Ginkgo Bioworks worth $27.6M.

  • Nicholas Investment Partners's largest Q3 2021 buy was Ginkgo Bioworks: 59,532 shares worth $27.6M.
  • Nicholas Investment Partners added most to Expand Energy Corp in Q3 2021, an estimated $7.8M increase.
  • Nicholas Investment Partners's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.2M.
  • Nicholas Investment Partners fully exited Zai Lab in Q3 2021, selling an estimated $25.1M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.37B portfolio in Q3 2021.
  • Nicholas Investment Partners opened 21 new positions and closed 28 in Q3 2021.
  • Nicholas Investment Partners's portfolio value fell 14% quarter-over-quarter to $1.37B.

Based on Nicholas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.